These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7027369)

  • 1. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 2. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serratia marcescens infections. Bacteriological study, antibiogram, and clinical significance].
    Paredes L; Fernández M; Paredes M; Fuenzalida P; Paredes L
    Rev Med Chil; 1974 Feb; 102(2):109-17. PubMed ID: 4157414
    [No Abstract]   [Full Text] [Related]  

  • 4. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
    Cook LN; Davis RS; Stover BH
    Pediatrics; 1980 Feb; 65(2):264-8. PubMed ID: 6986597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 7. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC; Jorgensen JH; Kaspar RL; Drutz DJ
    Am J Med; 1977 Jun; 62(6):902-10. PubMed ID: 326046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and laboratory evaluation of amikacin].
    Borowski J; Musierowicz A; Dzierzanowska D; Niedźwiecka M; Gruszecki W
    Pol Tyg Lek; 1979 Oct; 34(44):1721-5. PubMed ID: 514892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and bacteriological evaluation of Amikin (Amikacin sulfate) by Bristol-Myers].
    Wencel J; Czaplicki M; Borkowski A; Malewski AW
    Pol Tyg Lek; 1978 Dec; 33(50):1937-8. PubMed ID: 733620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of amikacin in hematology].
    Bauters F; Jouet JP
    Lille Med; 1979; 24(6):494-7. PubMed ID: 502743
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
    Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
    Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL; Rhame FS; Pesanti EL; Axline SG
    JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serratia marcescens ("B. prodigiosus"), the germ of hospital infections].
    Modde H
    Rev Med Suisse Romande; 1974 Apr; 94(4):325-32. PubMed ID: 4596928
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].
    Lode H; Grunert K; Koeppe P; Langmaack H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1684-6. PubMed ID: 1030080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amikacin in the child: efficacy, tolerance, effects on the intestinal microbial ecosystem].
    Mathieu H; Lambert-Zechovsky N; Beaufils F; Blum C; Binger E; Guillot M
    Nouv Presse Med; 1979 Oct; 8(42):3482-91. PubMed ID: 537901
    [No Abstract]   [Full Text] [Related]  

  • 17. [Statistical observation of urinary tract infections by Serratia marcescens].
    Kamiryo Y; Sakatoku J
    Hinyokika Kiyo; 1983 Apr; 29(4):401-10. PubMed ID: 6203384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.
    Wielunsky E; Drucker M; Cohen T; Reisner SH
    Isr J Med Sci; 1983 Nov; 19(11):1006-8. PubMed ID: 6662682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of pediatric experience with amikacin.
    Yow MD
    Am J Med; 1977 Jun; 62(6):954-8. PubMed ID: 868913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.